The Role of Obsessive-Compulsive Factors in the Treatment of Binge-Eating Disorders: A Post-Hoc Analysis of a Double-Blind, Placebo-Controlled Trial of Dasotraline

被引:0
|
作者
Loebel, Antony [1 ]
Goldman, Robert [1 ]
Citrome, Leslie [1 ]
Siu, Cynthia [1 ]
Tsai, Joyce [1 ]
Kent, Justine [1 ]
机构
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
关键词
Binge Eating Disorder; Obsessive Compulsive Disorder; Dasotraline;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M68
引用
收藏
页码:112 / 113
页数:2
相关论文
共 50 条
  • [11] OBSESSIVE-COMPULSIVE DISORDER - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CLOMIPRAMINE IN 27 PATIENTS
    JENIKE, MA
    BAER, L
    SUMMERGRAD, P
    WEILBURG, JB
    HOLLAND, A
    SEYMOUR, R
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (10): : 1328 - 1330
  • [12] Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (05) : 716 - 721
  • [13] A double-blind, placebo-controlled trial of folic acid addition in fluoxetine for treatment of obsessive-compulsive disorder
    Tural, O
    Corapçioglu, A
    Bosgelmez, S
    Köroglu, G
    Duman, C
    Önder, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S307 - S307
  • [14] SERTRALINE IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER - 2 DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    CHOUINARD, G
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 : 37 - 41
  • [15] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [16] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [17] Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial
    Geller, DA
    Wagner, KD
    Emslie, G
    Murphy, T
    Carpenter, DJ
    Wetherhold, E
    Perera, P
    Machin, A
    Gardiner, C
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (11): : 1387 - 1396
  • [18] Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial
    Grilo, Carlos M.
    Ivezaj, Valentina
    Yurkow, Sydney
    Tek, Cenk
    Wiedemann, Ashley A.
    Gueorguieva, Ralitza
    PSYCHOLOGICAL MEDICINE, 2024, 54 (12) : 3334 - 3344
  • [19] Seasonal Antimicrobial Activity of the Airway: Post-Hoc Analysis of a Randomized Placebo-Controlled Double-Blind Trial
    Buonfiglio, Luis G. Vargas
    Calderon, Oriana G. Vanegas
    Cano, Marlene
    Simmering, Jacob E.
    Polgreen, Philip M.
    Zabner, Joseph
    Gerke, Alicia K.
    Comellas, Alejandro P.
    NUTRIENTS, 2020, 12 (09) : 1 - 9
  • [20] Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial
    McElroy, SL
    Hudson, JI
    Malhotra, S
    Welge, JA
    Nelson, EB
    Keck, PE
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (07) : 807 - 813